Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -32.87% is 56% below its 5-year average of -21.10%, near the low end of its 5-year range (-32.87%–-8.77%).
16.07% below its 12-month average of -28.32%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -8.77%.
RETURN ON ASSETS (ROA)
-32.87%
RETURN ON ASSETS (ROA) AVG TTM
-28.32%
RETURN ON ASSETS (ROA) AVG 3Y
-25.80%
RETURN ON ASSETS (ROA) AVG 5Y
-21.10%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-16.07%
CURRENT VS 3Y AVG
-27.38%
CURRENT VS 5Y AVG
-55.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-1.95%
vs the sector median at left
Treace Medical Concepts, Inc.
Market Cap
$259.49M
Return on Assets (ROA)
-32.87%
TTM Avg
-28.32%
3Y Avg
-25.80%
5Y Avg
-21.10%
Market Cap
$259.56M
Return on Assets (ROA)
-13.63%
TTM Avg
-10.56%
3Y Avg
-3.47%
5Y Avg
-3.69%
Market Cap
$259.14M
Return on Assets (ROA)
-35.96%
TTM Avg
-58.88%
3Y Avg
-82.10%
5Y Avg
-113.46%
Market Cap
$259.12M
Return on Assets (ROA)
-34.24%
TTM Avg
-52.06%
3Y Avg
-53.17%
5Y Avg
-44.53%
Market Cap
$258.63M
Return on Assets (ROA)
-25.09%
TTM Avg
-72.59%
3Y Avg
-80.80%
5Y Avg
-146.30%
Market Cap
$261.27M
Return on Assets (ROA)
-35.62%
TTM Avg
-26.42%
3Y Avg
-45.47%
5Y Avg
-51.35%
Market Cap
$261.43M
Return on Assets (ROA)
-37.07%
TTM Avg
-27.27%
3Y Avg
-64.53%
5Y Avg
-52.03%
Market Cap
$256.47M
Return on Assets (ROA)
-29.15%
TTM Avg
-33.84%
3Y Avg
-33.85%
5Y Avg
-31.54%
Market Cap
$262.92M
Return on Assets (ROA)
-45.18%
TTM Avg
-124.83%
3Y Avg
-176.38%
5Y Avg
-195.56%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Treace Medical Concepts, Inc. (TMCI) | $259.49M | -32.87% | -28.32% | -25.80% | -21.10% |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | -13.63% | -10.56% | -3.47% | -3.69% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | -35.96% | -58.88% | -82.10% | -113.46% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $259.12M | -34.24% | -52.06% | -53.17% | -44.53% |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | -25.09% | -72.59% | -80.80% | -146.30% |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | -35.62% | -26.42% | -45.47% | -51.35% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | -37.07% | -27.27% | -64.53% | -52.03% |
| AC Immune S.A. (ACIU)vs › | $256.47M | -29.15% | -33.84% | -33.85% | -31.54% |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | -45.18% | -124.83% | -176.38% | -195.56% |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | -2.06% | -16.77% | -17.09% | -12.28% |
ROA
-32.9%
ROE
-87.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -30.96% |
| 2024-12-31 | -25.68% |
| 2023-12-31 | -19.66% |
| 2022-12-31 | -26.92% |
| 2021-12-31 | -14.59% |
| 2020-12-31 | -8.77% |
| 2019-12-31 | -14.35% |
